[go: nahoru, domu]

Cereblon E3 ligase modulator: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

24 January 2024

13 December 2023

11 December 2023

8 December 2023

5 December 2023

4 December 2023

20 October 2023

12 October 2023

14 August 2023

13 April 2023

21 May 2022

4 April 2022

5 February 2022

13 December 2021

11 October 2021

11 September 2021

3 September 2021

13 August 2021

  • curprev 16:0516:05, 13 August 2021Shinryuu talk contribs 49,628 bytes −6,600 While Apremilast is an immunomodulator and a phthalimide, it is usually not considered an IMiD (cf. PMID 22646699). The molecular target of apremilast is not Cereblon but PDE4. Additionally, the division of IMiDs (or any drugs) into generations is common but arbitrary and more of a marketing ploy than scientific - pomalidomide is sometimes classified as second gen (e.g. PMID 16085014) and sometimes as third gen (e.g. PMID 21921051). Minor note: there is no fig. 2 in the article. undo

11 July 2021

8 February 2021

14 January 2021

31 December 2020

24 December 2020

2 May 2020

15 April 2020

1 April 2020

3 March 2020

29 February 2020

30 July 2019

10 December 2018

6 October 2018

3 July 2018

15 June 2018

2 November 2017

21 August 2016

6 August 2016

5 August 2016

3 August 2016

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)